-transparent.png){kind=logo}
We report the fatal disease course of 2 aged patients with rheumatoid arthritis (RA). Both had respiratory complaints after 10-15 weeks of treatment with methotrexate (MTX). After withdrawal of MTX, and despite the use of corticosteroids and ventilatory support, both died of respiratory failure. Post mortem examination showed extensive pulmonary fibrosis, bronchiolitis obliterans, and hyperplasia of type II pneumocytes. To our knowledge, this is the first report of fatal pulmonary fibrosis following short courses of low dose MTX therapy for RA.
Related Publications
M J van der Veen, and
J J Dekker, and
H J Dinant, and
R M van Soesbergen, and
J W Bijlsma
November 1985,
Archives of internal medicine,
M J van der Veen, and
J J Dekker, and
H J Dinant, and
R M van Soesbergen, and
J W Bijlsma
June 1993,
Clinical rheumatology,
M J van der Veen, and
J J Dekker, and
H J Dinant, and
R M van Soesbergen, and
J W Bijlsma
March 1991,
Thorax,
M J van der Veen, and
J J Dekker, and
H J Dinant, and
R M van Soesbergen, and
J W Bijlsma
January 1992,
Thorax,
M J van der Veen, and
J J Dekker, and
H J Dinant, and
R M van Soesbergen, and
J W Bijlsma
June 1990,
Ryumachi. [Rheumatism],
M J van der Veen, and
J J Dekker, and
H J Dinant, and
R M van Soesbergen, and
J W Bijlsma
April 1995,
The Journal of rheumatology,
M J van der Veen, and
J J Dekker, and
H J Dinant, and
R M van Soesbergen, and
J W Bijlsma
November 1995,
The Journal of rheumatology,
M J van der Veen, and
J J Dekker, and
H J Dinant, and
R M van Soesbergen, and
J W Bijlsma
October 1983,
Arthritis and rheumatism,
M J van der Veen, and
J J Dekker, and
H J Dinant, and
R M van Soesbergen, and
J W Bijlsma
October 1991,
The Medical journal of Australia,
M J van der Veen, and
J J Dekker, and
H J Dinant, and
R M van Soesbergen, and
J W Bijlsma
January 1980,
The Journal of rheumatology,
